| 000 | 01063 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250517042942.0 | ||
| 264 | 0 | _c20160820 | |
| 008 | 201608s 0 0 eng d | ||
| 022 | _a1873-2518 | ||
| 024 | 7 |
_a10.1016/j.vaccine.2015.07.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOsterhaus, A D M E | |
| 245 | 0 | 0 |
_aProceedings Fifth ESWI Influenza Conference. _h[electronic resource] |
| 260 |
_bVaccine _cDec 2015 |
||
| 300 |
_a6947-8 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCommunicable Disease Control _xmethods |
| 650 | 0 | 4 | _aCongresses as Topic |
| 650 | 0 | 4 | _aHealth Policy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfluenza Vaccines |
| 650 | 0 | 4 |
_aInfluenza, Human _xdrug therapy |
| 650 | 0 | 4 |
_aOseltamivir _xtherapeutic use |
| 650 | 0 | 4 |
_aPandemics _xprevention & control |
| 700 | 1 | _aVanlangendonck, Chris | |
| 773 | 0 |
_tVaccine _gvol. 33 _gno. 49 _gp. 6947-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2015.07.001 _zAvailable from publisher's website |
| 999 |
_c25091318 _d25091318 |
||